BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2007
View Archived Issues
Merck & Co. reports preliminary in vivo results of novel DPP-IV inhibitor
Read More
Adenovirus-based HIV-1 vaccine safe in humans
Read More
Snapshots of new study results for epilepsy treatments
Read More
Enzon files IND for HIF-1alpha antagonist
Read More
Novel agents for treating neurological disorders disclosed in recent patents
Read More
New JAK3 inhibitors emerge from Rigel R&D
Read More
U.S. orphan drug status for INNO-406 in Gleevec-resistant or intolerant CML
Read More
Novel therapeutic agents for gastrointestinal disorders claimed in recent patents
Read More
Galapagos extends and expands drug discovery collaboration with Amgen
Read More
DOR receives payment from Sigma-Tau for rights to negotiate orBec alliance
Read More
Sequenom and Qiagen collaborate on prenatal diagnostics
Read More
OSI licenses GKA program for type 2 diabetes to Lilly
Read More
New phase IIb trial begins for microplasmin in vitrectomy
Read More
Xytis signs CRADA for neboglamine in cocaine addiction
Read More
Semafore completes Series B equity financing
Read More
Tengion studies urinary neobladder construct in phase II
Read More
ALK-Abello and Schering-Plough form immunotherapy alliance
Read More
Launch of Merck Serono
Read More
GSK completes acquisition of Domantis
Read More
TargeGen selects Jak2 inhibitor TG-101348 for clinical development
Read More
Shionogi and Nippon Kayaku end Japanese development agreement for NS-75B
Read More
ATC shows potential for combination therapy with tipranavir
Read More
HY-10275 meets endpoints in insomnia study
Read More
HGF gene plasmid shows potential to improve perfusion in patients with CLI
Read More